• LAST PRICE
    4.9800
  • TODAY'S CHANGE (%)
    Trending Up0.3200 (6.8670%)
  • Bid / Lots
    4.7000/ 1
  • Ask / Lots
    5.9500/ 19
  • Open / Previous Close
    4.7200 / 4.6600
  • Day Range
    Low 4.6200
    High 5.1500
  • 52 Week Range
    Low 2.5800
    High 11.6700
  • Volume
    95,102
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 4.66
TimeVolumeEPIX
09:32 ET5264.72
09:43 ET2004.81
09:45 ET2004.81
09:48 ET1004.81
09:50 ET2004.81
09:52 ET3004.8
09:54 ET3004.71
09:56 ET6654.64
09:59 ET1004.71
10:01 ET2004.62
10:06 ET3004.65
10:10 ET3004.7
10:12 ET3004.69
10:14 ET1004.7
10:15 ET2004.71
10:17 ET1004.75
10:21 ET2004.745
10:24 ET3004.765
10:26 ET2004.765
10:28 ET1004.78
10:30 ET23795
10:32 ET7384.95
10:33 ET4004.88
10:35 ET1004.87
10:37 ET4004.89
10:39 ET2004.87
10:44 ET4005.02
10:46 ET2005.015
10:50 ET7004.92
10:53 ET1924.8647
10:57 ET1004.9
11:00 ET12785.15
11:02 ET4095.05
11:08 ET1805.115
11:09 ET8005.03
11:13 ET7005.1
11:15 ET1005.03
11:22 ET9755.06
11:36 ET1005.11
11:40 ET2005.05
11:56 ET6005.11
12:02 ET5005.13
12:12 ET17815.03
12:18 ET2715.03
12:23 ET19285.01
12:30 ET1005.03
12:34 ET1005.03
12:36 ET1005.03
12:38 ET8004.96
12:48 ET1004.995
12:50 ET18004.96
12:59 ET3004.94
01:01 ET1004.98
01:03 ET30005
01:08 ET1005.01
01:10 ET1005
01:12 ET5005
01:14 ET1005
01:17 ET1005
01:19 ET1005
01:21 ET1005
01:24 ET2005
01:26 ET4275.02
01:28 ET6005
01:30 ET6005
01:33 ET3034.99
01:35 ET5004.99
01:37 ET1004.98
01:39 ET4005
01:46 ET3005
01:48 ET5005
01:50 ET1005.03
01:51 ET2205.03
01:55 ET11005.02
01:57 ET1005.02
02:00 ET1005.02
02:02 ET6005.02
02:06 ET1005.03
02:08 ET2005.01
02:09 ET1005.01
02:13 ET1005.01
02:15 ET11005.01
02:24 ET1005.005
02:26 ET18385.02
02:29 ET1005.02
02:31 ET2005.02
02:33 ET1005.02
02:36 ET7005.03
02:38 ET2005.01
02:40 ET2005.02
02:42 ET9595.02
02:44 ET1005.025
02:45 ET2005.02
02:47 ET1005
02:49 ET1005.015
02:51 ET3005.01
02:54 ET1005.02
02:56 ET1005.02
02:58 ET1005.02
03:00 ET2005.02
03:02 ET7005.02
03:03 ET5625.01
03:07 ET2005.02
03:09 ET6005.01
03:12 ET1005.02
03:14 ET5005.026
03:16 ET2005.02
03:18 ET4005
03:20 ET7005
03:21 ET3005.02
03:25 ET9005.0225
03:27 ET16005.01
03:30 ET8005.01
03:32 ET4004.99
03:34 ET7005.01
03:36 ET4005.02
03:38 ET4005.01
03:39 ET4005.03
03:41 ET7005.01
03:43 ET5004.98
03:45 ET3004.98
03:48 ET14005.01
03:50 ET4004.98
03:52 ET21474.97
03:54 ET12004.99
03:56 ET15934.98
03:57 ET32004.98
03:59 ET171274.98
Data delayed at least 15 minutes.
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesEPIX
ESSA Pharma Inc
206.7M
-7.9x
---
United StatesGLSI
Greenwich Lifesciences Inc
205.7M
-21.3x
---
United StatesACRV
Acrivon Therapeutics Inc
204.7M
-2.3x
---
United StatesFBLG
Fibrobiologics Inc
202.9M
-5.2x
---
United StatesPYXS
Pyxis Oncology Inc
201.4M
-2.4x
---
United StatesPRLD
Prelude Therapeutics Inc
212.6M
-2.0x
---
As of 2024-06-20

Company Information

ESSA Pharma Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is focused on developing proprietary therapies for the treatment of patients with prostate cancer. Its lead candidate, EPI-7386, is an oral, small molecule that inhibits the N-terminal domain of the androgen receptor (AR). The Company is completing the initial Phase I clinical development of EPI-7386 as a monotherapy treatment for patients with metastatic castration-resistant prostate cancer (mCRPC). The Company is also developing ANITen bAsed Chimera (ANITAC) AR NTD degraders to suppress androgen biology.

Contact Information

Headquarters
999 West Broadway, Suite 720VANCOUVER, BC, Canada V5Z 1K5
Phone
778-331-0962
Fax
778-331-0962

Executives

Non-Executive Independent Chairman of the Board
Richard Glickman
President, Chief Executive Officer, Director
David Parkinson
Chief Financial Officer
David Wood
Chief Operating Officer, Executive Vice President
Peter Virsik
Executive Vice President, Chief Medical Officer
Alessandra Cesano

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$206.7M
Revenue (TTM)
$0.00
Shares Outstanding
44.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.80
EPS
$-0.63
Book Value
$3.30
P/E Ratio
-7.9x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.